By
Anders Bylund
|
More Articles
August 12, 2011
|
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of defibrillation and CPR-gear specialist Zoll Medical (Nasdaq: ZOLL ) climbed as high as 10.1% today on fairly big trading volume.
So what: This stock plunged face-first on Monday because of a dire new risk outlined in the freshly filed 10-Q: LifeVest products might not get the wide market access they were expected to gain. Today, Zoll executives took part in a conference call arranged by Jefferies to calm frazzled investor nerves -- and it looks like that worked to some degree.
Now what: I don't know what was said during that fateful call, but the bulk of today's climb started along with the phone action and ended when they hung up. Whatever the message -- nitpicked by a supposedly independent doctor selected by Jefferies -- ZOLL is still set to close the week some 22% lower. And before writing that off as just getting caught in the general market panic, consider that sector rivals Medtronic (NYSE: MDT ) , CONMED (Nasdaq: CNMD ) , and Boston Scientific (NYSE: BSX ) all dropped about half as far. On the other hand, ZOLL investors have already ridden the LifeVest to 86% gains over the last year.
Interested in more info on ZOLL Medical? Add it to your watchlist.
RSS Headlines
Fool UK